Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy.
Saved in:
| Title: | Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy. |
|---|---|
| Authors: | Fantini M; Precision Biologics, Inc., Bethesda, MD, United States., Arlen PM; Precision Biologics, Inc., Bethesda, MD, United States., Tsang KY; Precision Biologics, Inc., Bethesda, MD, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Nov 24; Vol. 14, pp. 1275904. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38077389 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fantini+M%22">Fantini M</searchLink>; Precision Biologics, Inc., Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Arlen+PM%22">Arlen PM</searchLink>; Precision Biologics, Inc., Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Tsang+KY%22">Tsang KY</searchLink>; Precision Biologics, Inc., Bethesda, MD, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Nov 24; Vol. 14, pp. 1275904. <i>Date of Electronic Publication: </i>2023 Nov 24 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38077389 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2023.1275904 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1275904 Titles: – TitleFull: Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fantini M – PersonEntity: Name: NameFull: Arlen PM – PersonEntity: Name: NameFull: Tsang KY IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 11 Text: 2023 Nov 24 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
